Implementation of Individualized Pain Management in Vaso-occlusive Pain Crisis
Utilization of specialty nurse practitioner driven teams and use of individualized pain protocols for patients admitted with vaso-occlusive pain crisis improves quality of life for patients with sickle cell disease, and decreased hospital stay times.
ONS Annual Congress Focuses on Increasing Nurse Comfort and Patient Understanding in Cancer Care
This year’s congress showcased strategies for communicating sensitive topics, patient experiences with immunotherapy treatments, updates in the utility of
medical cannabis, and more.
A Quick Look at the 2022 AACR Annual Meeting
This year’s conference highlighted advances in natural killer cells, CD39 and KRAS G12C inhibitors, and CAR T-cell therapies.
Caring for a Pregnant Patient With Cancer
Approximately 140 in 100,000 pregnant women receive a cancer diagnosis. Of these diagnoses, 0.1% are considered malignant tumors.
Does the CDC’s Proposed Opioid Prescribing Guideline Fall Short on Drug Testing?
Although the CDC has put forth a strong effort to improve its opioid guidelines, many providers still feel that more can be done.
The Future of CAR T-Cell Therapy: Will Off-the-Shelf Options Soon Enter the Playing Field?
Approval of off-the-shelf CAR T-Cell therapy options would provide greater accessibility and benefit to patients, say experts.
Complex Cancer Cases: Caring for a Patient With Malignant Bowel Obstruction
Laura Zitella, MS, RN, ACNP-BC, AOCN, reviews a case study where a 52-year-old female patient with metastatic colorectal carcinoma begins experiencing diffuse abdominal pain.
CURE® Magazine Names Margaret Campbell, BSN, RN, as 2022 Extraordinary Healer®
At the 47th Annual ONS Congress, CURE® Media group honored oncology nurses at their 2022 Extraordinary Healer® Award ceremony.
Carbone Cancer Center Expert Shares Biggest Updates in Kidney Cancer Treatment
In this episode of “The Vitals,” Hamid Emamekhoo, MD, discusses the evolving treatment landscape of kidney cancer.
Expert Discusses Best Practices for Managing Breast Cancer–Related Toxicities
Charles L. Loprinzi, MD, discusses the efficacy of agents like gabapentin and olanzapine to combat breast cancer treatment-related pains and speaks to the future of nonestrogenic toxicity management within this space.
Olanzapine Significantly Reduces CINV in Patients Receiving MEC
Reimagining Frailty Screenings in Head and Neck Cancer
Screening for Pain and Depression is Not Enough in Cancer Care
Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPC
2 Clarke Drive Cranbury, NJ 08512